NewEdge Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.1M | Sell |
22,679
-1,040
| -4% | -$564K | 0.04% | 426 |
|
|
2025
Q4 | $13.7M | Buy |
23,719
+2,767
| +13% | +$1.56M | 0.05% | 340 |
|
|
2025
Q3 | $10.2M | Sell |
20,952
-8,317
| -28% | -$3.87M | 0.05% | 393 |
|
|
2025
Q2 | $11.9M | Buy |
29,269
+7,289
| +33% | +$3.05M | 0.06% | 327 |
|
|
2025
Q1 | $10.9M | Sell |
21,980
-8,509
| -28% | -$4.61M | 0.07% | 298 |
|
|
2024
Q4 | $15.9M | Buy |
30,489
+843
| +3% | +$463K | 0.1% | 209 |
|
|
2024
Q3 | $18.3M | Buy |
29,646
+4,950
| +20% | +$2.93M | 0.12% | 183 |
|
|
2024
Q2 | $13.7M | Buy |
24,696
+1,784
| +8% | +$1.02M | 0.1% | 205 |
|
|
2024
Q1 | $13.3M | Buy |
22,912
+3,824
| +20% | +$2.15M | 0.12% | 185 |
|
|
2023
Q4 | $10.2M | Buy |
19,088
+2,066
| +12% | +$1M | 0.1% | 207 |
|
|
2023
Q3 | $8.62M | Buy |
17,022
+1,333
| +8% | +$710K | 0.09% | 212 |
|
|
2023
Q2 | $8.19M | Sell |
15,689
-834
| -5% | -$450K | 0.09% | 221 |
|
|
2023
Q1 | $9.47M | Sell |
16,523
-416
| -2% | -$234K | 0.12% | 182 |
|
|
2022
Q4 | $5.46M | Buy |
16,939
+2,582
| +18% | +$1.37M | 0.15% | 146 |
|
|
2022
Q3 | $7.28M | Buy |
14,357
+1,526
| +12% | +$854K | 0.12% | 183 |
|
|
2022
Q2 | $6.97M | Buy |
12,831
+1,031
| +9% | +$567K | 0.12% | 182 |
|
|
2022
Q1 | $6.97M | Sell |
11,800
-194
| -2% | -$111K | 0.11% | 184 |
|
|
2021
Q4 | $8M | Buy |
11,994
+5,186
| +76% | +$3.24M | 0.12% | 167 |
|
|
2021
Q3 | $3.89M | Buy |
6,808
+1,758
| +35% | +$965K | 0.1% | 202 |
|
|
2021
Q2 | $2.5M | Buy |
5,050
+457
| +10% | +$216K | 0.07% | 267 |
|
|
2021
Q1 | $2.1M | Buy |
4,593
+85
| +2% | +$40.6K | 0.06% | 273 |
|
|
2020
Q4 | $2.1M | Sell |
4,508
-3,294
| -42% | -$1.54M | 0.07% | 247 |
|
|
2020
Q3 | $3.44M | Buy |
7,802
+733
| +10% | +$303K | 0.12% | 174 |
|
|
2020
Q2 | $2.56M | Buy |
7,069
+851
| +14% | +$285K | 0.1% | 196 |
|
|
2020
Q1 | $1.76M | Buy |
6,218
+4,235
| +214% | +$1.34M | 0.09% | 216 |
|
|
2019
Q4 | $644K | Sell |
1,983
-206
| -9% | -$62.5K | 0.03% | 455 |
|
|
2019
Q3 | $626K | Buy |
2,189
+1,208
| +123% | +$346K | 0.03% | 434 |
|
|
2019
Q2 | $288K | Buy |
981
+109
| +13% | +$30K | 0.02% | 535 |
|
|
2019
Q1 | $239K | Buy |
+872
| New | +$217K | 0.02% | 587 |
|
|
2018
Q4 | – | Sell |
-1,527
| Closed | -$373K | – | 712 |
|
|
2018
Q3 | $373K | Buy |
1,527
+137
| +10% | +$31.5K | 0.03% | 439 |
|
|
2018
Q2 | $286 | Sell |
1,390
-44
| -3% | -$9.34K | 0.03% | 422 |
|
|
2018
Q1 | $291K | Buy |
1,434
+145
| +11% | +$30.4K | 0.03% | 358 |
|
|
2017
Q4 | $261K | Sell |
1,289
-386
| -23% | -$73.9K | 0.04% | 345 |
|
|
2017
Q3 | $324K | Buy |
1,675
+1,351
| +417% | +$245K | 0.05% | 270 |
|
|
2017
Q2 | $57.6K | Buy |
+324
| New | +$54.4K | 0.01% | 508 |
|
Other funds holding TMO
VCM
NewEdge Advisors's TMO Position: Q1 2026 in Review
NewEdge Advisors reduced its Thermo Fisher Scientific (TMO) stake by 4.4% in Q1 2026, selling an estimated $564K and leaving 22,679 shares worth $11.1M. The position accounts for 0.04% of the portfolio, ranked #426.
NewEdge Advisors first reported a position in TMO in Q2 2017 and has held it in 35 quarters since. The position peaked at $18.3M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- NewEdge Advisors held 22,679 shares of Thermo Fisher Scientific worth $11.1M as of Q1 2026.
- NewEdge Advisors sold 1,040 Thermo Fisher Scientific shares in Q1 2026, an estimated $564K.
- Thermo Fisher Scientific made up 0.04% of NewEdge Advisors's portfolio in Q1 2026, its #426 holding.
- NewEdge Advisors first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 35 quarters since.
- NewEdge Advisors's Thermo Fisher Scientific position peaked at $18.3M in Q3 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.